Skip to content

Dossier · TTMI · Dormant

TTMI · TTM Technologies, Inc.

Last analysed ·

Current thesis

AI-data-center + defense PCB/RF picks-and-shovels re-accelerating: V-rebounded off the ~$172 June-10 dip to ~$194 (3% under ATH $200.68); $4B 2026 revenue goal (May 27 Investor Day), book-to-bill 1.41, sell-side PTs $205–$215 still above price. The $200/ATH breakout is the continuation trigger; no company catalyst until the ~Aug-5 Q2 print.

Invalidation trigger

Weekly close below ~$170 (June-10 higher-low shelf / rising 20-week support), OR Q2 print (~Aug 5) book-to-bill <1.0 or revenue below the $930M guide-low signaling AI+defense order rollover.

Thesis status

Open commitment scored if the trigger above fires How this is scored →

Current Thesis

AI-data-center and defense PCB/RF picks-and-shovels in a re-accelerating leg. After Q1 2026 (reported 2026-04-29) printed a beat-and-raise revenue $846M (+30% YoY) vs $787M consensus, non-GAAP EPS $0.75 vs $0.67, backlog $1.6B, book-to-bill 1.41, ~80% of sales tied to AI + defense the stock ran to a $200.68 all-time high, dipped to ~$172 by 2026-06-10, then V-rebounded to $194.05 by the 2026-06-12 close (after-hours ~$197), roughly 3% under the ATH. Sell-side targets ($205–$215) still sit above price, and management's 2026-05-27 Investor Day put a $4B annual-revenue exit-rate goal on the table. The next company catalyst is the ~Aug-5 Q2 print, so the runway between now and then trades on order flow and a $200 breakout test.

Bull Case

  • Beat-and-raise printed 2026-04-29: rev $846M (+30% YoY) beat $787M est; non-GAAP EPS $0.75 vs $0.67; adj EBITDA $132.9M (15.7% margin). The Q1 reaction was +15.07% a one-day repricing, not a fade.
  • Q2 2026 guide accelerates: $930–970M rev (+27–33% YoY), EPS $0.82–0.88 (+41–52% YoY). EPS growth outrunning revenue growth signals operating leverage.
  • $4B revenue target framed publicly: CEO floated a $4B 2026 revenue goal on 2026-05-18 and at the 2026-05-27 Investor Day an explicit exit-rate ambition that re-anchors the growth narrative above current run-rate (~$3.1B TTM revenue, +23% YoY).
  • Demand outpaces shipments: backlog $1.6B, book-to-bill 1.41 (2026-04-29 call). A reading above 1.4 is the cleanest live confirmation that orders are still leading revenue.
  • Defense backlog is contracted and multi-year: RTX/Raytheon awarded a multi-year LTAMDS radar-component agreement worth up to $200M (announced 2026-01-28) decorrelated from AI-capex timing and a recurring contributor to the ~80% AI+defense mix.
  • Balance sheet refinanced for expansion (2026-06-03): 8-K disclosed a new $1.0B multi-currency revolver due 2031-05-01 plus a $400M Term Loan B repriced at SOFR+1.75% maturing 2030-05-01 extends maturities and funds capacity (Penang, Syracuse) without an equity raise.
  • Sell-side still chasing: Needham reiterated Buy, $208 PT on 2026-06-11; Stifel $205, Truist $215, B.Riley $208, all Buy, all raised. Price ~$194 remains below every target; 4-analyst rating is Strong Buy, ~$209 average.

Bear Case

  • Air-pocket fragility just demonstrated: the name shed ~9% from ~$189.60 (2026-06-04) to ~$172 (2026-06-10) before rebounding. A 105x trailing P/E (forward ~43x) leaves no cushion when an AI-capex headline turns.
  • Re-entering directly into resistance: at $194 the stock is back into the $200.68 ATH zone on its third test a fresh position here buys the wall, not a clean breakout.
  • Insider selling into strength: a 2026-05-28 filing flagged John Mayer share sales of ~79,000 shares, right as the stock pressed highs.
  • It is a cyclical, capital-intensive PCB maker (15.7% EBITDA margin), not a secular-monopoly silicon franchise. Multiples de-rate violently on the first growth-deceleration quarter; GuruFocus tags it overvalued (GF Score 76, P/E 105).
  • Backlog-conversion risk: a hyperscaler capex pause or a defense continuing-resolution/budget delay hits realization of the $1.6B backlog directly.
  • Narrative is going public: mainstream "manufacturing boom" and "$1,000 invested 20 years ago" retrospective pieces (2026-06-05) signal the story is reaching retail late-stage, though price targets are still rising rather than rolling over.

Setup & Price Structure

  • Last close $194.05 (2026-06-12, +3.65%), after-hours ~$197.00; market cap ~$20.15B on ~103.8M shares; 52-wk range ~$35–$200.68.
  • The 2026-06-10 dip to ~$172 carved a higher low above the prior breakout base and held; the bounce back to ~$194 in two sessions reasserts the uptrend.
  • Resistance is the round-$200 / $200.68 ATH magnet. A weekly close above $200.68 on expanding volume is the continuation trigger; rejection there sets up a retest of the ~$172–$180 shelf.
  • Per the the momentum read read: an accelerating, cluster-confirmed leader with sell-side targets above spot and a pending breakout treats high RSI and ATH proximity as confirmation. The qualifier is the just-printed 9% round-trip, which argues for sizing to a clear-but-not-maximum conviction rather than a fat pitch, and favors adds on a confirmed $200 break over chasing into the wall.

Catalyst Calendar (next 30 days)

  • No confirmed company catalyst inside the next 30 days. Q2 2026 earnings expected ~2026-08-05 (some sources estimate 2026-07-29 to 2026-08-03); avoid fresh entries within three trading days of the confirmed date once set.
  • Ongoing analyst flow: PT reiterations/raises clustering ($205–$215 range) remain the live tape between now and the print watch for any target cut as an early narrative-crack signal.
  • Defense order headlines: incremental LTAMDS / RF-assembly awards (follow-ons to the 2026-01-28 $200M Raytheon agreement) can move the tape intra-quarter.
  • Macro: AI-capex commentary from hyperscaler prints and any defense-budget/CR headlines are the exogenous catalysts during the company's quiet stretch.

What Would Change Our Mind

  • Structure break: a weekly close below ~$170 losing the 2026-06-10 higher-low shelf and the rising 20-week support flips the trend from accelerating to broken and invalidates the continuation read.
  • Fundamental rollover: the ~Aug-5 Q2 print showing book-to-bill below 1.0, or revenue below the $930M guide-low, would signal AI+defense order deceleration and kill the second-derivative thesis.
  • Mix dilution: AI+defense share of sales dropping below ~70% (from ~80% at Q1) would mean the high-multiple narrative is diluting back toward commodity PCB.
  • Theme flip: the AI-hardware-supply-chain theme turning saturated sell-side targets cut, peers (optical/PCB/substrate names) breaking down together with no replacement order catalyst.

Correlation Notes

  • AI-capex beta: trades with the AI-server hardware/optical supply chain (CLS, FN, networking-optical and substrate peers) and reacts to hyperscaler capex guidance cluster breakdowns there would drag TTMI regardless of its own backlog.
  • Defense electronics: the RTX/Raytheon LTAMDS exposure ties a slice of the book to defense-budget and prime-contractor order cycles, which run on a different clock than AI-capex and provide partial decorrelation.
  • Reshoring/tariff tailwind: grouped with US-manufacturing-buildout narratives; sensitive to tariff and onshoring-policy headlines.
  • Rate sensitivity: post-2026-06-03 refinancing (SOFR+1.75% TLB, $1.0B revolver), carrying cost is floating-rate linked a sharp move in front-end rates is a second-order input to the cost structure.

Notes

  • Earnings blackout: Q2 2026 ~2026-08-05 (some sources 7/29-8/3). avoid any entry within 3 trading days of confirmed date.
  • Book-to-bill is the key acceleration tell 1.41 as of Q1 (4/29). <1.0 on next print = thesis dead.
  • ~80% of sales = AI + defense (mgmt 4/29). Watch if mix drops <70% narrative dilution.
  • Extended name: +168% YTD, ~5% under ATH $200.68, RSI ~73.5 (6/4). Per momentum rule, extension is confirmation not a defer reason; but size to HIGH not SUPREME given mean-reversion risk.
  • Archetype: picks & shovels, NOT a6 retail squeeze institutionally driven with sell-side PT cluster + fundamental backing.
  • Earnings blackout: Q2 2026 ~2026-08-05 (some sources estimate 2026-07-29 to 2026-08-03). Avoid fresh entries within 3 trading days of the confirmed date.
  • Book-to-bill is the key acceleration tell 1.41 as of Q1 (4/29). Below 1.0 on the next print = thesis dead.
  • ~80% of sales = AI + defense (mgmt 4/29). Watch if mix drops below ~70% narrative dilution.
  • Raytheon LTAMDS $200M multi-year award is JAN-28-2026 news, not a fresh June catalyst don't double-count it as new flow.
  • Recent volatility: ~9% drop 6/4→6/10 (~$172) then V-rebound to $194.05 (6/12 close, AH ~$197), ~3% under ATH $200.68. Mean-reversion risk is live size HIGH not SUPREME; favor adds on a confirmed >$200 break over chasing into resistance.
  • May-28 insider sale (John Mayer ~79,000 sh) into strength monitor for further Form 4 selling.
  • 6/3 refinancing: $1.0B revolver due 2031, $400M Term Loan B at SOFR+1.75% due 2030 funds AI+defense capacity, no equity raise.
  • Picks-and-shovels supplier, NOT a retail squeeze institutionally driven with sell-side PT cluster ($205-215) + fundamental backing.

Related · shared themes